Schedule I drugs (C-I) are recognized for medicinal use and can be prescribed.

Study for the Ohio Multistate Pharmacy Jurisprudence Examination. Prepare with flashcards and multiple choice questions, each with hints and explanations. Ace your exam!

Multiple Choice

Schedule I drugs (C-I) are recognized for medicinal use and can be prescribed.

Explanation:
Schedule I drugs are classified as controlled substances that have a high potential for abuse and are not accepted for medical use in the United States. This classification means that they cannot be legally prescribed or dispensed under federal law. Drugs in this category include substances like heroin and lysergic acid diethylamide (LSD). The fact that they are deemed to have no accepted medicinal use is crucial in understanding their legal status. While there may be discussions about potential therapeutic benefits for certain Schedule I substances, such as cannabis or psilocybin, they are not recognized or approved for medical prescribing at the federal level as of October 2023. Therefore, the assertion that Schedule I drugs can be prescribed is incorrect, validating the choice that states it is false.

Schedule I drugs are classified as controlled substances that have a high potential for abuse and are not accepted for medical use in the United States. This classification means that they cannot be legally prescribed or dispensed under federal law. Drugs in this category include substances like heroin and lysergic acid diethylamide (LSD).

The fact that they are deemed to have no accepted medicinal use is crucial in understanding their legal status. While there may be discussions about potential therapeutic benefits for certain Schedule I substances, such as cannabis or psilocybin, they are not recognized or approved for medical prescribing at the federal level as of October 2023.

Therefore, the assertion that Schedule I drugs can be prescribed is incorrect, validating the choice that states it is false.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy